42538-64-7

Usage

Chemical Properties

White powder

Upstream product

• 4530-20-5 BOC-glycine 

Downstream Products

• 34573-36-9 N-[(1,1-dimethylethoxy)carbonyl]glycine chloromethyl ester 
• 3655-05-8 tert-butoxycarbonylglycine p-nitrophenylester 
• 1404113-26-3 2-oxo-2-(4-(pyrrolidin-1-yl)phenyl)ethyl 2-(tert-butoxycarbonylamino)acetate 
• 1404113-23-0 2-(3-(dimethylamino)phenyl)-2-oxoethyl 2-(tert-butoxycarbonylamino)acetate 
• 1404113-20-7 2-(4-(dimethylamino)phenyl)-2-oxoethyl 2-(tert-butoxycarbonylamino)acetate 
• 1404113-17-2 2-oxo-2-p-tolylethyl 2-(tert-butoxycarbonylamino)acetate 
• 1404113-14-9 2-(4-chlorophenyl)-2-oxoethyl 2-(tert-butoxycarbonylamino)acetate 
• 1404113-13-8 2-(4-fluorophenyl)-2-oxoethyl 2-(tert-butoxycarbonylamino)acetate 
• 83316-95-4 2-oxo-2-phenylethyl 2-(tert-butoxycarbonylamino)acetate 
• 947180-95-2 C₂₈H₃₁ClN₄O₁₀S 
• 1009102-77-5 C₃₁H₃₇ClN₄O₁₀S 
• 1009102-76-4 C₃₀H₃₅ClN₄O₁₀S 
• 132090-36-9 Boc₂-Gly-Gly-Phe-Leu-OBzl 
• 132090-35-8 Boc₂-Gly-Phe-Leu-OBzl 

Relevant academic research and scientific papers

Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline

With the aim to investigate the effect of different heterocyclic rings linked to the 4-aminoquinoline nucleus on the antimalarial activity, a set of 7-chloro-N-(heteroaryl)-methyl-4-aminoquinoline and 7-chloro-N-(heteroaryl)-4- aminoquinoline was synthesi

Aminoacyl Prodrug Derivatives and Medicaments for the Treatment of Thromboembolitic Disorders

The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.

AMINOACYL PRODRUGS

The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.

ACYLOXYMETHYLCARBAMATE PRODRUGS OF OXAZOLIDINONES

The present invention relates to acyloxymethylcarbamate oxazolidinones. The compounds of the present invention have potent activity with excellent oral bioavailability against Gram-positive and Gram-negative bacteria.